Blood Biomarker Accurately Predicts Cardiac Risk in Older Adults
Aug 17, 2026
High levels of the heart stress biomarker NT-proBNP in the blood of older adults is linked to higher cardiovascular disease risk and all-cause mortality.
Read More –ctDNA From Blood Equals or Bests Tissue-Based Tests in Triple Negative Breast Cancer
Aug 19, 2026“Off-the-Shelf” CAR T-Cell Therapy Shows Mixed Early Results
Aug 19, 2026Multi-Layered Screening Identifies Potential ADC Targets in Cervical Cancer
Aug 19, 2026Aggressive Rhabdomyosarcoma Defined by Cell State Rather than Gene Fusion
Aug 19, 2026Genetic Newborn Screening Could Help Detect Early-Onset Cancer Risk
Aug 14, 2026Pancreatic Cancer Daraxonrasib Escape Reveals RAS-Driven Vulnerabilities
Aug 13, 2026Heart Failure Treatment May Benefit from Pomegranate and Walnut Compound
Aug 19, 2026
Heartbeat-Powered Pacemaker Could Last a Patient’s Lifetime
Aug 19, 2026
Nearly All FDA-Cleared AI Medical Devices Lack Evidence of Patient Benefit
Aug 19, 2026
Gut Bacteria Reveal Link Between Diet and Cardiometabolic Health
Aug 19, 2026
Special Lipid Nanoparticle Shows Promise for Delivering RNA Therapies
Aug 19, 2026
Gene Therapy Could Reverse Genetic Heart Disease, Spare Children from Transplants
Aug 19, 2026
News & Features
Gene-Edited CAR T Expands Rare Disease Horizons
August 01, 2026Combining CAR T with CRISPR or TALEN is enabling more precise, scalable cell therapies for autoimmune, fibrotic, and genetic disorders.
From Mila to Many: Making Ultra-Rare Disease Therapies More Accessible
August 01, 2026Newer options like the therapies being developed by Forster and colleagues at Nerai Biosciences, alongside others like potentially curative gene therapies, are on the horizon…
Drug Repurposing’s Next Challenge: Turning Discoveries Into Treatments
August 01, 2026The U.S. Food and Drug Administration (FDA) is now actively involving patients, researchers, and clinicians in efforts to prioritize drug repurposing in areas where commercial…
Cancer Diagnostics: Droplet Digital PCR Testing for HPV+ Cancer in the Clinic
In this IPM webinar, Chad Brenner, PhD, will describe the development, validation, and clinical implementation of MyHPVscore™, a droplet digital PCR-based circulating tumor HPV DNA assay performed on the Bio-Rad QX200 platform.
Chad Brenner, PhD
Associate Professor of Otolaryngology – Head & Neck Surgery
University of Michigan
CRISPR Screen Identifies Gene Editing Barriers
Aug 13, 2026A high-resolution screening platform has identified cellular barriers that impact the effectiveness of non-viral genome editing, opening a window through which to enhance the potency…
Personalized T-Cell Therapy Induces Complete Remission of Metastatic Kidney Cancer
Aug 12, 2026Scientists report a remarkable response to a personalized T-cell therapy in a teenager with a metastatic, treatment-resistant kidney tumor.
Estrogen Therapy Could Reduce Dementia Risk in Older Women
Aug 12, 2026Older women who use estrogen therapy are about 35% less likely to display severe Alzheimer's related damage in their brain tissue after death and 39%…
Podcast Series
Behind the Breakthroughs
Join host Jonathan D. Grinstein, PhD, North American Editor for Inside Precision Medicine, as he uncovers the stories behind the pioneers driving the precision medicine revolution.
Stay up to date with the latest episodes of Behind the Breakthroughs by subscribing to the IPM eNewsletter.
